Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | APL-1202 |
Trade Name | |
Synonyms | APL1202|APL 1202 |
Drug Descriptions |
APL-1202 is a methionine aminopeptidase II inhibitor that potentially inhibits tumor angiogenesis and induces apoptosis (European Urology Supplements, Volume 15, Issue 3, e215). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C162480 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
APL-1202 | APL-1202 | 0 | 1 |
APL-1202 + BCG solution | APL-1202 BCG solution | 0 | 1 |
APL-1202 + Tislelizumab | APL-1202 Tislelizumab | 0 | 1 |